Jefferies Reiterates Buy Rating on Nektar Therapeutics (NKTR)

Go back to Jefferies Reiterates Buy Rating on Nektar Therapeutics (NKTR)
Nektar Therapeutics (NASDAQ: NKTR) Delayed: 76.08 +2.44 (3.31%)
Previous Close $73.64    52 Week High $19.98 
Open $75.00    52 Week Low $10.52 
Day High $76.22    P/E N/A 
Day Low $73.43    EPS $-1.45 
Volume 727,438